OpenAI rolls out GPT-6 Sol and Luna, faster and cheaper models built on Astra

OpenAI began distributing two new models in the GPT-6 family, Sol and Luna, to paying ChatGPT Work and Codex users and via the API today. There was no launch event, no technical report, no public benchmarks — just a single post on X repeated three times.

Access and timing

The rollout follows subscription tiers. Plus, Pro, Business, Enterprise and Edu customers see both models in Work and Codex starting today. Free and Go subscribers are limited to Luna only, and only in the desktop app for now. In the API, both models are available to all tiers without restriction, letting developers test them immediately in production.

Behind the architecture

According to the company, Sol and Luna were built on the advances that produced GPT-6 Astra, the larger, more expensive model released earlier. The stated goal is to deliver "a significant portion of the strengths" of Astra in models that are faster and cheaper to run at scale. OpenAI also cites improvements in caching and inference efficiency but provided no figures — no percentage speedup, no per-token cost reduction, no quantitative comparison against Astra or GPT-5.

What wasn't said, and why it matters

The announcement includes no general-availability date for Free and Go users on web or mobile, no new API pricing details, and no updated SLA commitment for Enterprise customers. It also remains unclear whether Sol and Luna replace existing models in the selector or sit on top of them. Without independent benchmarks or first-party data, developers will have to run their own evaluations to decide whether switching makes sense.

Bottom line for developers and organizations

The quiet launch signals a strategy of rapid, lower-cost iterations rather than generational leaps. For organizations already paying for higher tiers, immediate access to two new models in Work and the API is an operational advantage. Anyone waiting for hard numbers before committing should hold off for the first community tests likely to appear in the coming days.